---
figid: PMC6695538__WJCC-7-1937-g001
figtitle: The crosstalk between estrogen receptor and growth factor receptor intracellular
  signaling pathways
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6695538
filename: WJCC-7-1937-g001.jpg
figlink: /pmc/articles/PMC6695538/figure/F1/
number: F1
caption: 'The crosstalk between estrogen receptor and growth factor receptor intracellular
  signaling pathways. Growth factor receptors (GFRs) activate the downstream PI3K/AKT/mTOR
  signaling pathway and the Cyclin D1/CDK4/6 complex, while the ER-E2 complex has
  the same effect[]. The Cyclin D1/CDK4/6 complex drives cell proliferation by inducing
  Rb phosphorylation and promotes cell cycle from G1 phase to S phase in the nucleus[].
  Targeted agents against the CDK4/6 pathway and the PI3K/AKT/mTOR pathway can trigger
  cell cycle arrest and control tumor progression. ER: Estrogen receptor; GFR: Growth
  factor receptor; CDK4/6: Cyclin-dependent kinase; PI3K: Phosphatidylinositol 3-kinase;
  PIP2: Phosphatidylinositol 4,5-biphosphate; PIP3: Phosphatidylinositol triphosphate;
  mTOR: Mammalian target of rapamycin; Rb: Retinoblastoma protein.'
papertitle: 'Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast
  cancer.'
reftext: Li-Tong Yao, et al. World J Clin Cases. 2019 Aug 6;7(15):1937-1953.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9451809
figid_alias: PMC6695538__F1
figtype: Figure
redirect_from: /figures/PMC6695538__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6695538__WJCC-7-1937-g001.html
  '@type': Dataset
  description: 'The crosstalk between estrogen receptor and growth factor receptor
    intracellular signaling pathways. Growth factor receptors (GFRs) activate the
    downstream PI3K/AKT/mTOR signaling pathway and the Cyclin D1/CDK4/6 complex, while
    the ER-E2 complex has the same effect[]. The Cyclin D1/CDK4/6 complex drives cell
    proliferation by inducing Rb phosphorylation and promotes cell cycle from G1 phase
    to S phase in the nucleus[]. Targeted agents against the CDK4/6 pathway and the
    PI3K/AKT/mTOR pathway can trigger cell cycle arrest and control tumor progression.
    ER: Estrogen receptor; GFR: Growth factor receptor; CDK4/6: Cyclin-dependent kinase;
    PI3K: Phosphatidylinositol 3-kinase; PIP2: Phosphatidylinositol 4,5-biphosphate;
    PIP3: Phosphatidylinositol triphosphate; mTOR: Mammalian target of rapamycin;
    Rb: Retinoblastoma protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RAPGEF5
  - AKT1
  - AKT2
  - AKT3
  - CCND1
  - CDK4
  - MTOR
  - WARS1
  - gfr
  - nac
  - Akt
  - Cdk4
  - Mtor
  - Tor
  - rb
  - anon-70Dc
  - Everolimus
---
